Admitting Its Limitations, Bio-Rad Contends SELDI Still Valuable for Biomarker Discovery | GenomeWeb
This article has been updated from a previous version to clarify the current and former affiliation of Lance Liotta and Emanuel Petricoin and the approach used by the University of Texas MD Anderson Cancer Center in attempting to reproduce Liotta and Petricoin's results.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.